Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell, Peripheral

Explore clinical trials studying Lymphoma, T-Cell, Peripheral. Study availability and eligibility vary by location and protocol.

239 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell, Peripheral trial results

Recruiting

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

NCT06072131

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of California, San Francisco Fresno Clovis, California, United States
  • University of California, Los Angeles Hem/ Onc Clinical Research Unit, Suite 600 Santa Monica, California, United States
  • University of Colorado School of Medicine Aurora, Colorado, United States
  • Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System Memorial Cancer Institute Pembroke Pines, Florida, United States
View all 69 locations
View Trial Details
Recruiting

Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

NCT05833724

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Chang Gung Memorial Hospital, Kaohsiung Kaohsiung City, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Far eastern memorial hospital New Taipei City, Taiwan
  • Taichung Veterans General Hospital Taichung, Taiwan
View Trial Details
Recruiting

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

NCT04068597

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +27 more
Locations
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Community Health Network Indianapolis, Indiana, United States
  • The Center for Cancer and Blood Disorders (CCBD) Bethesda, Maryland, United States
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
View all 39 locations
View Trial Details
Recruiting

A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)

NCT07234162

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Hospital Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital, CMU Beijing, Beijing Municipality, China
View all 51 locations
View Trial Details
Recruiting

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

NCT06131801

Conditions
ALL, AML, Acute Lymphocytic Leukemia, +50 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Recruiting

Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain

NCT07624838

Conditions
CD30-Positive Peripheral T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Hospital Universitario A Coruña A Coruña, Spain
  • Hospital Universitari Son Llàtzer Palma de Mallorca, Balearic Islands, Spain
  • Hospital Universitari Son Espases Palma de Mallorca, Balearic Islands, Spain
  • ICO Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
View all 37 locations
View Trial Details

Related conditions